⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1009207 | 0.74 | — | — | |
| SCHEMBL3930 | 0.74 | — | — | |
| SCHEMBL157176 | 0.74 | — | — | |
| SCHEMBL1330514 | 0.74 | — | — | |
| SCHEMBL1066271 | 0.74 | — | — | |
| SCHEMBL20237102 | 0.71 | — | — | |
| SCHEMBL330940 | 0.70 | — | — | |
| SCHEMBL8445834 | 0.70 | — | — | |
| SCHEMBL7593420 | 0.70 | — | — | |
| SCHEMBL1298536 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900726-B1 | RESIN COMPOSITION AND COMPOSITE STRUCTURE CONTAINING RESIN | HEXCEL COMPOSITES LTD (GB) | 2020-04-08 | — | — | EP | disclosed |
| EP-2276808-B1 | IMPROVED MOULDING PROCESSES | HEXCEL COMPOSITES LTD (GB) | 2018-06-20 | — | — | EP | disclosed |
| US-9695312-B2 | Resin composition and composite structure containing resin | HEXCEL COMPOSITES LIMITED (GB) | 2017-07-04 | — | — | US | disclosed |
| EP-2900726-A2 | RESIN COMPOSITION AND COMPOSITE STRUCTURE CONTAINING RESIN | Hexcel Composites Limited (GB) | 2015-08-05 | — | — | EP | disclosed |
| US-20150210847-A1 | RESIN COMPOSITION AND COMPOSITE STRUCTURE CONTAINING RESIN | HEXCEL COMPOSITES LIMITED (GB) | 2015-07-30 | — | — | US | disclosed |
| EP-1957073-B1 | MEDICINAL DRUG | OTSUKA PHARMA CO LTD (JP) | 2014-04-23 | — | — | EP | disclosed |
| US-8551999-B2 | Heterocyclic compound and pharmaceutical composition thereof | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-10-08 | — | — | US | disclosed |
| EP-2612858-A1 | STAT3/5 activation inhibitor | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-07-10 | — | — | EP | disclosed |
| US-20120322807-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. | 2012-12-20 | — | — | US | disclosed |
| WO-2012150866-A1 | PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND USES THEREOF | INDUSTRIAL RESEARCH LIMITED (NZ) | 2012-11-08 | — | — | WO | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
| US-20050261527-A1 | Process for the production of primary alcohols | DRENT EIT | 2005-11-24 | — | — | US | disclosed |
| EP-1542951-A1 | PROCESS FOR THE PRODUCTION OF PRIMARY ALCOHOLS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2005-06-22 | — | — | EP | disclosed |
| US-20050113622-A1 | Catalytic trimerization of olefinic monomers | SHELL OIL COMPANY | 2005-05-26 | — | — | US | disclosed |
| WO-2005039758-A1 | CATALYTIC TRIMERIZATION OF OLEFINIC MONOMERS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2005-05-06 | — | — | WO | disclosed |
| US-20040242949-A1 | Process for the telomerization of a conjugated diene, catalyst and bidentate ligand useful therein | DRENT EIT (NL) | 2004-12-02 | — | — | US | disclosed |
| EP-1444176-A2 | BIDENTATE LIGAND FOR THE TELOMERIZATION OF DIENES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 2004-08-11 | — | — | EP | disclosed |
| US-20040133050-A1 | Process for the production of primary alcohols | SHELL OIL COMPANY | 2004-07-08 | — | — | US | disclosed |
| WO-2004029014-A1 | PROCESS FOR THE PRODUCTION OF PRIMARY ALCOHOLS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2004-04-08 | — | — | WO | disclosed |
| WO-2003040065-A2 | BIDENTATE LIGAND FOR THE TELOMERIZATION OF DIENES | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 2003-05-15 | — | — | WO | disclosed |